Lawrence Otto Klein, CBO & COO at CRISPR Therapeutics AG (CRSP), sold 116,500 shares at $74.90 ($8.8M) on 2020-06-24, disclosed to the SEC on 2020-06-26.
Open-market sale of $8.8M CRSP by CBO & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.90 | 6,600 | $494K | 5.6% |
| 2 | $74.90 | 6,600 | $494K | 5.6% |
| 3 | $75.32 | 12,175 | $917K | 10.4% |
| 4 | $75.32 | 12,175 | $917K | 10.4% |
| 5 | $75.93 | 15,966 | $1.2M | 13.7% |
| 6 | $75.93 | 15,966 |
| $1.2M |
| 13.7% |
| 7 | $75.94 | 3,934 | $299K | 3.4% |
| 8 | $75.94 | 3,934 | $299K | 3.4% |
| 9 | $76.26 | 2,913 | $222K | 2.5% |
| 10 | $76.26 | 2,913 | $222K | 2.5% |
| 11 | $76.50 | 800 | $61K | 0.7% |
| 12 | $76.50 | 22,700 | $1.7M | 19.7% |
| 13 | $75.18 | 4,912 | $369K | 4.2% |
| 14 | $75.18 | 4,912 | $369K | 4.2% |
| Total | $75.75 avg | 116,500 | $8.8M | 100% |
| Filing → |
| ORKA | SELL | 2026-09-01 | $6.9M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |